CoChat
Sign Up
Cited by 263

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation

Sugimachi, K, Matsumura, T, Hirata, H, Uchi, R, Ueda, M, Ueo, H, Shinden, Y, Iguchi, T, Eguchi, H, Shirabe, K, Ochiya, T, Maehara, Y, Mimori, K·2015·British Journal of Cancer
DOI 10.1038/bjc.2014.621PMC PMC4453648
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/bjc.2014.621

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Exosomal miR in the serum was associated with malignant progression of HCC. (A, B) Exosomes were purified from serum of HCC patients using ultracentrifuge method and examined by electron microscopy; (A) scale bar, 200 nm and (B) scale bar, 100 nm. (C) The exosome extract from serum after an ultracentrifuge method was analysed by western blotting. The data demonstrated that extracts were enriched with exosomal marker protein TSG101. Supernatant of cultured cancer cell lines were used as control. (D–G) miR-718 expression levels in the exosomes from serum of HCC patients who underwent LT were examined according to clinicopathological parameters. (D) Tumour diameter, (E) histological differentiation, (F) vascular invasion, (G) recurrence of the disease. Data represent the means±s.d.
Figure 1 Exosomal miR in the serum was associated with malignant progression of HCC. (A, B) Exosomes were purified from serum of HCC patients using ultracentrifuge method and examined by electron microscopy; (A) scale bar, 200 nm and (B) scale bar, 100 nm. (C) The exosome extract from serum after an ultracentrifuge method was analysed by western blotting. The data demonstrated that extracts were enriched with exosomal marker protein TSG101. Supernatant of cultured cancer cell lines were used as control. (D–G) miR-718 expression levels in the exosomes from serum of HCC patients who underwent LT were examined according to clinicopathological parameters. (D) Tumour diameter, (E) histological differentiation, (F) vascular invasion, (G) recurrence of the disease. Data represent the means±s.d.CC BY-NC-SA · PubMed Central
Figure 2 miR-718 inhibited cell proliferation and targeted HOXB8 gene. (A, B) Induction of miR-718 inhibited the proliferation of HCC cells. (A) miR-718 expression levels in HuH7 cells transfected with pre-miR-718 were significantly higher than those of negative control (nc) cells. (B) The cell proliferation ratio of HuH7 cells transfected with pre-miR-718 were significantly suppressed compared to the negative control (*P<0.01). (C) Overall survival curves of the low and high HOXB8 expression groups for 58 HCC patients who underwent hepatectomy. The patients with high HOXB8 expression showed significantly poorer long-term prognosis after hepatectomy.
Figure 2 miR-718 inhibited cell proliferation and targeted HOXB8 gene. (A, B) Induction of miR-718 inhibited the proliferation of HCC cells. (A) miR-718 expression levels in HuH7 cells transfected with pre-miR-718 were significantly higher than those of negative control (nc) cells. (B) The cell proliferation ratio of HuH7 cells transfected with pre-miR-718 were significantly suppressed compared to the negative control (*P<0.01). (C) Overall survival curves of the low and high HOXB8 expression groups for 58 HCC patients who underwent hepatectomy. The patients with high HOXB8 expression showed significantly poorer long-term prognosis after hepatectomy.CC BY-NC-SA · PubMed Central
Figure 3 miR-718 inhibited the transcription of HOXB8 gene. (A) Sequences of the miR-718 binding sites in the 3′UTRs of transcripts encoding HOXB8. (B) Luciferase analyses in HuH7 and PLC/PRF/5 cell lines. HOXB8 3′ UTR luciferase vector+miR-718 transfectants showed lower luciferase activities than did control cells. Relative luciferase levels were calculated by the following: (Sample Luc/Sample Renilla)/(Control Luc/Control Renilla). Luc, raw firefly luciferase activity; Renilla, Renilla activity (internal transfection control); Pre-miR n.c., pre-miR negative control.
Figure 3 miR-718 inhibited the transcription of HOXB8 gene. (A) Sequences of the miR-718 binding sites in the 3′UTRs of transcripts encoding HOXB8. (B) Luciferase analyses in HuH7 and PLC/PRF/5 cell lines. HOXB8 3′ UTR luciferase vector+miR-718 transfectants showed lower luciferase activities than did control cells. Relative luciferase levels were calculated by the following: (Sample Luc/Sample Renilla)/(Control Luc/Control Renilla). Luc, raw firefly luciferase activity; Renilla, Renilla activity (internal transfection control); Pre-miR n.c., pre-miR negative control.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 33

  1. Barry CT, D’Souza M, McCall M, Safadjou S, Ryan C, Kashyap R, Marroquin C, Orloff M, Almudevar A, Godfrey TE (2012) Micro RNA expression profiles as adjunctive data to assess the risk of hepatocellular carcinoma recurrence after liver transplantation. Am J Transplant 12 (2): 428–437. · DOI
  2. Cereghetti DM, Lee PP (2014) Tumor-derived exosomes contain microRNAs with immunological function: implications for a novel immunosuppression mechanism. MicroRNA 2 (3): 194–204. · DOI
  3. Hagiwara K, Ochiya T, Kosaka N (2014) A paradigm shift for extracellular vesicles as small RNA carriers: from cellular waste elimination to therapeutic applications. Drug Deliv Transl Res 4: 31–37. · DOI
  4. Han ZB, Zhong L, Teng MJ, Fan JW, Tang HM, Wu JY, Chen HY, Wang ZW, Qiu GQ, Peng ZH (2012) Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation. Mol Oncol 6 (4): 445–457. · DOI
  5. Hannafon BN, Ding WQ (2013) Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci 14 (7): 14240–14269. · DOI
  6. Hu G, Drescher KM, Chen XM (2012) Exosomal miRNAs: biological properties and therapeutic potential. Front Genet 3: 56.
  7. Hu QY, Jiang H, Su J, Jia YQ (2013) MicroRNAs as biomarkers for hepatocellular carcinoma: a diagnostic meta-analysis. Clin Lab 59 (9-10): 1113–1120.
  8. Katsuda T, Kosaka N, Ochiya T (2013) The roles of extracellular vesicles in cancer biology: towards the development of novel cancer biomarkers. Proteomics 14 (4-5): 412–425. · DOI
  9. Li L, Guo Z, Wang J, Mao Y, Gao Q (2012) Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Dig Dis Sci 57 (11): 2910–2916. · DOI
  10. Liu AM, Yao TJ, Wang W, Wong KF, Lee NP, Fan ST, Poon RT, Gao C, Luk JM (2012) Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ open 2 (2): e000825. · DOI
  11. Llovet JM (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40 (3): 225–235. · DOI
  12. Mathivanan S, Fahner CJ, Reid GE, Simpson RJ (2012) ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 40 (Database issue): D1241–D1244. · DOI
  13. Mazzaferro V, Chun YS, Poon RT, Schwartz ME, Yao FY, Marsh JW, Bhoori S, Lee SG (2008) Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 15 (4): 1001–1007. · DOI
  14. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (11): 693–699. · DOI
  15. Murakami Y, Toyoda H, Tanahashi T, Tanaka J, Kumada T, Yoshioka Y, Kosaka N, Ochiya T, Taguchi YH (2012) Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease. PLoS One 7 (10): e48366. · DOI
  16. Nishida N, Mimori K, Fabbri M, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M (2011) MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin Cancer Res 17 (9): 2725–2733. · DOI
  17. Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Inoue H, Nagahara H, Murayama S, Mori M (2005) Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin Cancer Res 11 (8): 2889–2893. · DOI
  18. Okita K (2006) Clinical aspects of hepatocellular carcinoma in Japan. Intern Med 45 (5): 229–233. · DOI
  19. Ono M, Kosaka N, Tominaga N, Yoshioka Y, Takeshita F, Takahashi RU, Yoshida M, Tsuda H, Tamura K, Ochiya T (2014) Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signal 7 (332): ra63. · DOI
  20. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, Garcia-Santos G, Ghajar C, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS, Wolchok JD, Chapman PB, Kang Y, Bromberg J, Lyden D (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18 (6): 883–891. · DOI · Paper page
  21. Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF (2011) Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 6 (12): e28486. · DOI
  22. Qu KZ, Zhang K, Li H, Afdhal NH, Albitar M (2011) Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol 45 (4): 355–360. · DOI
  23. Roessler S, Long EL, Budhu A, Chen Y, Zhao X, Ji J, Walker R, Jia HL, Ye QH, Qin LX, Tang ZY, He P, Hunter KW, Thorgeirsson SS, Meltzer PS, Wang XW (2012) Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology 142 (4): 957–966 e12. · DOI
  24. Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA (2012) Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 7 (1): e29770. · DOI
  25. Shah N, Sukumar S (2010) The Hox genes and their roles in oncogenesis. Nat Rev Cancer 10 (5): 361–371. · DOI
  26. Simons M, Raposo G (2009) Exosomes—vesicular carriers for intercellular communication. Curr Opin Cell Biol 21 (4): 575–581. · DOI
  27. Sugimachi K, Shirabe K, Taketomi A, Soejima Y, Iguchi T, Takeishi K, Toshima T, Aishima S, Tajima T, Maehara Y (2011) Prognostic significance of preoperative imaging in recipients of living donor liver transplantation for hepatocellular carcinoma. Transplantation 91 (5): 570–574. · DOI
  28. Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uhciyama H, Ikegami T, Harada N, Yamashita Y, Sugimachi K, Kayashima H, Iguchi T, Maehara Y (2009) Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation 87 (4): 531–537. · DOI
  29. Taylor DD, Gercel-Taylor C (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110 (1): 13–21. · DOI
  30. Volk ML, Hernandez JC, Su GL, Lok AS, Marrero JA (2007) Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Cancer Biomark 3 (2): 79–87. · DOI
  31. Wang H, Hou L, Li A, Duan Y, Gao H, Song X (2014a) Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma. Biomed Res Int 2014: 864894.
  32. Wang L, Yao M, Dong Z, Zhang Y, Yao D (2014b) Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring. Tumour Biol 35 (1): 9–20. · DOI
  33. Yamamoto Y, Kosaka N, Tanaka M, Koizumi F, Kanai Y, Mizutani T, Murakami Y, Kuroda M, Miyajima A, Kato T, Ochiya T (2009) MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers 14 (7): 529–538. · DOI

Cited by

Sorted by citations

See all 263

Metadata

Authors
Sugimachi, K., Matsumura, T., Hirata, H., Uchi, R., Ueda, M., Ueo, H., Shinden, Y., Iguchi, T., Eguchi, H., Shirabe, K., Ochiya, T., Maehara, Y., & Mimori, K.
Venue
British Journal of Cancer
Publisher
Springer Science and Business Media LLC
Published
2015-01-13
Volume
112
Issue
3
Pages
532-538
ISSN
  • 0007-0920
  • 1532-1827
DOI
10.1038/bjc.2014.621
PMC
PMC4453648
Cited by
263
References
2
Language
en
Licence
www.springer.com/tdm (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation. https://app.cochat.ai/papers/10.1038/bjc.2014.621
The paper
Sugimachi, K., Matsumura, T., Hirata, H., Uchi, R., Ueda, M., Ueo, H., Shinden, Y., Iguchi, T., Eguchi, H., Shirabe, K., Ochiya, T., Maehara, Y., & Mimori, K. (2015). Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation. British Journal of Cancer. https://doi.org/10.1038/bjc.2014.621